Quinestradol

This classification denotes a therapeutic estrogen with the molecular formula C23H32O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 422L8173W8, chemically known as 3-(cyclopentyloxy)estra-1,3,5(10)-triene-16alpha,17beta-diol but generally known as quinestradol, which bears US NIH Compound Identifier 14431. European Medicines Agency schedules Quinestradol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10210MIG. The term QUINESTRADOL is an International Non-Proprietary Name. QUINESTRADOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule quinestradol under HS 29372300 and SITC 54153. As of Q4 2014, QUINESTRADOL remains the US FDA Preferred Term for this commodity. Quinestradol bears US NLM identifiers UMLS ID C0072864 and NCI Concept Code C76999. SMILES: OC1C2(C(C3C(CC2)c2c(CC3)cc(OC3CCCC3)cc2)CC1O)C.